T. Rowe Price Associates’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $216K | Buy |
|
|||||
|
2025
Q2 | $194K | Buy |
|
|||||
|
2025
Q1 | $214K | Buy |
|
|||||
|
2024
Q4 | $307K | Buy |
|
|||||
|
2024
Q3 | $219K | Buy |
|
|||||
|
2024
Q2 | $214K | Buy |
|
|||||
|
2024
Q1 | $233K | Buy |
|
|||||
|
2023
Q4 | $280K | Buy |
|
|||||
|
2023
Q3 | $155K | Buy |
|
|||||
|
2023
Q2 | $212K | Buy |
|
|||||
|
2023
Q1 | $198K | Buy |
|
|||||
|
2022
Q4 | $204K | Buy |
|
|||||
|
2022
Q3 | $271K | Buy |
|
|||||
|
2022
Q2 | $117K | Buy |
|